GanickD., Leukemia presenting as a cerebrospinal fluid disease without bone marrow involvement, Med. Paed. Oncol., 11:229–232, 1983.
2.
EvansA.E., GilbertE.S., and ZandstraR., The increasing incidence of central nervous system leukemia in children, Cancer, 26:404–409, 1970.
3.
RhomesJ.A., and HustuH.D., Comparison of two methods of preventing central nervous system leukemia, Blood, 42:349–357, 1973.
4.
PriceR.A., and JamiesonP.A., The central nervous system in childhood leukemia, 11. The subacute leukoencephalopathy, Cancer, 35:306–318, 1974.
5.
McintoshS., and KlatshinE., Chronic neurological disturbance in childhood leukemia, Cancer, 37:853–857, 1976.
6.
PizzoP., Reversible dementia temporally associated with intraventriculartherapy with methotrexate in a child with acute myelogenous leukemia, J. Paediatr, 88:131–133,1976.
7.
EiserC., How leukemia affects a child's schooling, Br. J. Soc. Clin. Psych., 19:365–368, 1980.
8.
EiserC., Effects of chronic illness on intellectual development, Arch. Dis. Child., 55:766–700, 1980.
9.
GoffJ.R., AndersonH.R., and PawazekM., Distractibility and memory deficits in long term survivors of acute lymphoblastic leukemia, Dev. Behavior. Paediatr., 1:158–163, 1980.
10.
InatiA., and SallenS., Efficacy and morbidity of central nervous system prophylaxis in childhood acute lymphoblastic leukemia. Eight years experience with cranial irradiation and intrathecal methotrexate, Blood, 61:297–303, 1983.
11.
GraeberJ.E., and StuartM.J., Spinal fluid procoagulant activity. A sensitive indicator of central nervous system damage, Lancet, 2 (8084):285–288, 1978.
12.
SimilaS., Brain damage in relation to irradiation and chemotherapy of the central nervous system, Lancet, 1 (8019): 1000–1001, 1977.
13.
RoydsJ.A., LilleymanJ.S., TimperleyW.R., and TaylorC.B., Cerebro-spinal fluid enolase isoenzymes and neurotoxicity in early treatment of acute lymphoblastic leukemia, Arch. Dis. Child., 59:266–269, 1984.
14.
KorintenbergR., PalmD., RubisA., and SchnellongG., EEG changes during intensified induction therapy of acute lymphoblastic leukemia, Neuropaediatric, 10 (4):332–347, 1979.
15.
MahoneyD.H., BrittC.W., KellawayP., and FernbackD.J., Childhood leukemia: Implications of EEG findings at time of diagnosis, J. Paediatr., 98:437–440, 1981.
16.
MizrachiE.M., Sensory evoked potentials: clinical applications in paediatrics, J. Paediatri., 97 (1):1–10, 1980.
17.
ShermanJ., Visual evoked potential basic concepts and clinical applications, J. Am. Optom. Assoc., 50(1):19–30, 1979.
MaccoliniE., FranzoniE., VerechiV., ., Visual evoked potentials in early and late central nervous system changes due to anti-leukemia treatment in children, Ital. J. Neurol. Sci., 3 (4):295–299, 1982.
22.
RussoA., TomarchioS., PeroG., ConsoliG., MarinaR., RizzariC, and SchiliroG., Abnormal visual evoked potentials in leukemic children after cranial irradiation, Med. Paed. Oncol., 13:313–317, 1985.
23.
StockardJ.J., Effects of physiologic and technical variables in latencies of pattern reversal evoked potentials, J. Electrophysiolog. Techn., 7:3–28, 1981.
24.
OchsJ.J., ParveyL.S., WhitakerJ.N., BowmanW.P., and ChienL.C., Serial cranial computed tomography scans in children with leukemia given two different forms of central nervous system therapy, J. Clin. Oncol., 1 (12):793–798, 1983.
25.
WendlingL.R., BleyerW.A., and CHIROD., Transient severe periventricular hypodensity after leukemic prophylaxis with cranial irradiation and intrathecal methotrexate, J. Comput. Assist. Tomogr., 2:502–505, 1978.
26.
EnzmannD.R., and LaneB., Enlargement of subarachnoid spaces and lateral ventricles in paediatric patients undergoing chemotherapy, J. Paed., 92 (4):535–539, 1978.
27.
CohenS.R., BrookesB.R., HerndonR.M., and MckhannG.M., A diagnostic index of active demyelination: Myelin basic protein in the cerebro-spinal fluid, Ann. Neurol., 8: 25–31, 1980.
28.
GangjiD., and RaemanG., Leukoencephalopathy and elevated levels of myelin basic protein in the cerebro-spinal fluid of patients with acute lymphoblastic leukemia, New Eng. J. Med., 303:19–21, 1980.
29.
DavisonA.N., Myelination, American Lectures in lowing Chemistry, Ed. KugelmassNewton I., Charles C Thomas, Springfield, Illinois, 1970.
30.
BeltonN.R., and AndersonJ.M., 2’ 3’ -cyclic nucleotide 3’ - phosophohydrolase in the developing human brain, Paediatric. Res. Soc. Abst. Arch. Dis. Child., 48:325, 1973.
31.
MizrachiE.M., Sensory evoked potentials: clinical applications in paediatrics, J. Paediatri., 97(1):1–10, 1980.